The jumRoll project draws together experts from relevant industries to develop a strategy for in silico Clinical Trials. There will be 5 events, attended by representatives from different industries: The events are taking place across Europe throughout 2014-15, over the project’s 24 month running time. Further information about each event can be found on their […]

Event 1 – Rome

The group of 45 experts met in Rome to discuss the future for in silico clinical trials. The first event brought together around 45 of the world’s experts from across academia, industry, healthcare, and regulatory agencies to discuss the development of in silico clinical trials (ISCT). The plan for the first event was to establish […]

Event 2 – Rome

The second jumRoll event brought together around 50 industrial research experts from the medical device and pharma industries with experience of – or an interest in – the conceptual and design stages of clinical trials to begin to add detail to the design of the process that will ultimately be recommended to the European Commission […]

Event 3 – Lyon

This was a public meeting for participants with systems expertise seeking to lay out the interactions required for success and create a list of “signed -up alliance enthusiasts” Event 3 was held in Lyon The Third Experts Meeting of the jumRoll project, took place at the Mercure Lyon Centre Saxe Lafayette Hotel in the aristocratic […]

Event 4 – Brussels

50 participants attended the fourth jumRoll event, identifying and discussing the challenges faced by in silico clinical trials and taking on responsibility for authorship and editing of the various sections of the Roadmap. Event 4 was held in Brussels   The jumRoll project’s fourth Event took place in Thon Hotels EU and the European Economic and Social Committee in Brussels, […]

Event 5 – Barcelona

jumRoll’s fifth and final event was hosted in Barcelona by the Agency for Health Quality and Assessment of Catalonia (AQuAS) on the 4th and 5th June 2015. The event brought together around 100 experts to review the final draft of the Roadmap to in silico Clinical Trials. Matt Gross presenting on Big Data analytics and in silico Research. Delegates were […]